Cancer Research UK on Facebook

Cancer Research UK on Twitter

Skip navigation

Acute myeloid leukaemia (AML) - A to Z

There is information for people affected by acute myeloid leukaemia (AML) on our CancerHelp UK website.

Below you can browse all content on this site about acute myeloid leukaemia (AML) - a form of leukaemia.

There are also separate A-Z pages for:

Acute myeloid leukaemia (AML) is a sub-category of Children's cancers and Acute leukaemia

News story: US researchers unveil womb cancer and acute leukaemia genomes
1 May 2013
Press Release: Cancer Research UK launches trial of new drug to treat acute childhood leukaemia
27 January 2012
Press Release: Cardiff scientists take on leukaemia with drugs personalised to individual patients
6 October 2009
News story: Gene network study sheds light on leukaemia
24 April 2009
Press Release: Scientists solve arsenic's cancer paradox
13 April 2008

Press Release: Scientists find new drug target for hard-to-treat leukaemia
29 March 2012
News story: Faulty enzyme linked to certain brain tumours
23 November 2009
News story: Scientists sequence genome of second patient with AML
6 August 2009
News story: DNA sequence of cancer patient decoded for first time
10 November 2008
News story: Study shows that mutation can cause leukaemia
10 April 2008

Updated: 17 September 2009

Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666) and the Isle of Man (1103).
A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F).
Registered address: Angel Building, 407 St John Street, London EC1V 4AD.

We would like your feedback, please fill in our survey